The Breakthrough T1D has launched a new Request for Applications (RFA) aimed at advancing understanding of how insulin dose impacts outcomes for people living with type 1 diabetes (T1D). Since individuals with T1D depend on lifelong insulin therapy to manage glucose control, prevent diabetic ketoacidosis (DKA), and reduce long-term complications, this initiative seeks to explore […]
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: